IL99214A0 - Hypoglycemic hydroxyurea derivatives - Google Patents

Hypoglycemic hydroxyurea derivatives

Info

Publication number
IL99214A0
IL99214A0 IL99214A IL9921491A IL99214A0 IL 99214 A0 IL99214 A0 IL 99214A0 IL 99214 A IL99214 A IL 99214A IL 9921491 A IL9921491 A IL 9921491A IL 99214 A0 IL99214 A0 IL 99214A0
Authority
IL
Israel
Prior art keywords
hypoglycemic
hydroxyurea derivatives
hydroxyurea
derivatives
benzofuranylmethyl
Prior art date
Application number
IL99214A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL99214A0 publication Critical patent/IL99214A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Furan Compounds (AREA)
IL99214A 1990-08-23 1991-08-16 Hypoglycemic hydroxyurea derivatives IL99214A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57274590A 1990-08-23 1990-08-23

Publications (1)

Publication Number Publication Date
IL99214A0 true IL99214A0 (en) 1992-07-15

Family

ID=24289181

Family Applications (2)

Application Number Title Priority Date Filing Date
IL99214A IL99214A0 (en) 1990-08-23 1991-08-16 Hypoglycemic hydroxyurea derivatives
IL11314195A IL113141A0 (en) 1990-08-23 1995-03-27 Intermediates for hypoglycemic hydroxyurea detivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL11314195A IL113141A0 (en) 1990-08-23 1995-03-27 Intermediates for hypoglycemic hydroxyurea detivatives

Country Status (22)

Country Link
US (4) US5334604A (fi)
EP (1) EP0544696B1 (fi)
JP (1) JPH0678326B2 (fi)
KR (1) KR930701420A (fi)
AT (1) ATE116971T1 (fi)
AU (1) AU645112B2 (fi)
CA (1) CA2087437A1 (fi)
DE (1) DE69106714T2 (fi)
DK (1) DK0544696T3 (fi)
ES (1) ES2067945T3 (fi)
FI (1) FI930772A (fi)
GR (1) GR3014913T3 (fi)
HU (1) HUT70153A (fi)
IE (1) IE64927B1 (fi)
IL (2) IL99214A0 (fi)
MX (1) MX9100804A (fi)
NO (1) NO930615L (fi)
NZ (1) NZ239514A (fi)
PT (1) PT98732A (fi)
TW (1) TW200470B (fi)
WO (1) WO1992003425A1 (fi)
ZA (1) ZA916644B (fi)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992003425A1 (en) * 1990-08-23 1992-03-05 Pfizer Inc. Hypoglycemic hydroxyurea derivatives
CN1045005C (zh) * 1993-04-30 1999-09-08 山之内制药株式会社 双噁二唑烷衍生物,含该化合物的药物组合物及其用途
US5428048A (en) * 1993-11-08 1995-06-27 American Home Products Corporation Aryl-N-hydroxyureas as inhibitors of 5-lipoxygenase and anto-arteriosclerotic agents
US5459154A (en) * 1993-11-08 1995-10-17 American Home Products Corporation N-hydroxyureas as 5-lipoxygenase inhibitors and inhibitors of oxidative modification of low density lipoprotein
US5468760A (en) * 1993-11-08 1995-11-21 American Home Products Corporation Aralkyl-N-hydroxyureas as inhibitors of 5-lipoxygenase and oxidation of low density lipoprotein
JP3354258B2 (ja) * 1993-12-03 2002-12-09 富山化学工業株式会社 新規なインドール類またはその塩
WO1995018125A1 (fr) * 1993-12-27 1995-07-06 Japan Tobacco Inc. Derive d'isoxazolidinedione et son utilisation
US5480896A (en) * 1994-01-27 1996-01-02 American Home Products Corporation Aralkyl-1,2,4-oxadiazolidine-3,5-diones as antihyperglycemic agents
CA2146701A1 (en) * 1994-04-11 1995-10-12 Takashi Fujita Heterocyclic compounds having anti-diabetic activity, their preparation and their use
US5420146A (en) * 1994-05-10 1995-05-30 American Home Products Corporation Di-oxadiazolidine derivatives as antihyperglycemic agents
US5532256A (en) * 1994-05-18 1996-07-02 American Home Products Corporation New azolidinediones and thiadiazolidinediones as antihyperglycemic agents
US5468762A (en) * 1994-05-18 1995-11-21 American Home Products Corporation Azolidinediones as antihyperglycemic agents
US5703096A (en) * 1994-10-07 1997-12-30 Sankyo Company, Limited Oxime derivatives, their preparation and their therapeutic use
US5641796A (en) * 1994-11-01 1997-06-24 Eli Lilly And Company Oral hypoglycemic agents
CZ293016B6 (cs) * 1995-06-01 2004-01-14 Sankyo Company Limited Benzimidazolové deriváty a farmaceutické prostředky s jejich obsahem
US5885997A (en) * 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
EP1270571B1 (en) 1996-07-19 2006-09-06 Takeda Pharmaceutical Company Limited Heterocyclic compounds, their production and use
KR20000068151A (ko) 1996-08-19 2000-11-25 미즈노 마사루 프로피온산 유도체 및 그의 용도
JP2001514663A (ja) * 1997-03-12 2001-09-11 エスモンド，ロバート ダブリュー． アルツハイマー病を処置または予防するための方法
DE19711616A1 (de) 1997-03-20 1998-09-24 Boehringer Mannheim Gmbh Verbessertes Verfahren zur Herstellung von Thiazolidindionen
TR199903096T2 (xx) 1997-06-18 2000-08-21 Smithkline Beecham P.L.C. Diabetin tiazolidinedion ve s�lfonil�re ile tedavisi.
NZ503794A (en) 1997-10-08 2002-09-27 Sankyo Co Benzimidazole and imidazopyridine derived heterocyclic compounds, pharmaceutical compositions and uses thereof
US20040058873A1 (en) * 1998-03-12 2004-03-25 Esmond Robert W. Method for treating or preventing Alzheimer's disease
NZ501896A (en) 1998-03-30 2000-11-24 Japan Tobacco Inc Process for producing isoxazolidinedione compound
WO2000026197A1 (en) * 1998-10-29 2000-05-11 Bristol-Myers Squibb Company Novel inhibitors of impdh enzyme
AU768994B2 (en) 1998-11-12 2004-01-15 Smithkline Beecham Plc Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
AR023700A1 (es) 1998-11-12 2002-09-04 Smithkline Beecham Plc Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
JP4316787B2 (ja) * 2000-01-11 2009-08-19 壽製薬株式会社 エーテル又はアミド誘導体、その製法並びにそれを含有する糖尿病治療剤、
GB0014969D0 (en) 2000-06-19 2000-08-09 Smithkline Beecham Plc Novel method of treatment
AU2002224138A1 (en) * 2000-12-05 2002-06-18 Nippon Chemiphar Co. Ltd. Peroxisome proliferator activated receptor d activators
US6716842B2 (en) 2002-04-05 2004-04-06 Warner-Lambert Company, Llc Antidiabetic agents
US8216609B2 (en) * 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
US8268352B2 (en) * 2002-08-05 2012-09-18 Torrent Pharmaceuticals Limited Modified release composition for highly soluble drugs
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3437664A (en) * 1966-03-18 1969-04-08 Velsicol Chemical Corp 1,2,4-oxadiazolidines
US3895023A (en) * 1973-02-06 1975-07-15 Du Pont Antiinflammatory 1,2,4-oxadiazolidine-3,5-diones
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
US4367234A (en) * 1980-07-28 1983-01-04 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
US4342771A (en) * 1981-01-02 1982-08-03 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
US4406910A (en) * 1981-06-15 1983-09-27 Shell Oil Company Pesticidal 3-(2,3-dihydro-2-alkylbenzofuran-7-yl)-5-(R-oxy)-1,3,4-oxadiazol-2(3H)-ones
US4617312A (en) * 1983-01-17 1986-10-14 Pfizer Inc. Aldose reductase inhibiting 5-(2-alkoxyphenyl) thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
WO1986007056A1 (en) * 1985-05-21 1986-12-04 Pfizer Inc. Hypoglycemic thiazolidinediones
US4758263A (en) * 1986-10-27 1988-07-19 Sandoz Ltd. 2-(2,5-difluorophenyl)-4-methyl-1,2,4-oxadiazolidine-3,5 diones
GB8713861D0 (en) * 1987-06-13 1987-07-15 Beecham Group Plc Compounds
US4895953A (en) * 1987-09-30 1990-01-23 American Home Products Corporation 2-Aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents
US4826990A (en) * 1987-09-30 1989-05-02 American Home Products Corporation 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents
MX15171A (es) * 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
HU217432B (hu) * 1988-03-08 2000-01-28 Pfizer Inc. Eljárás tiazolidin-dion-származékok és az ezeket tartalmazó gyógyszerkészítmények előállítására, a vegyületek és a készítmények
WO1989008650A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Thiazolidinedione hypoglycemic agents
US5239080A (en) * 1989-02-08 1993-08-24 Takeda Chemical Industries, Ltd. Oxazole compounds and their use as antidiabetic and bone-reduction inhibitory agents
WO1992003425A1 (en) * 1990-08-23 1992-03-05 Pfizer Inc. Hypoglycemic hydroxyurea derivatives
US5468760A (en) * 1993-11-08 1995-11-21 American Home Products Corporation Aralkyl-N-hydroxyureas as inhibitors of 5-lipoxygenase and oxidation of low density lipoprotein
US5428048A (en) * 1993-11-08 1995-06-27 American Home Products Corporation Aryl-N-hydroxyureas as inhibitors of 5-lipoxygenase and anto-arteriosclerotic agents
US5459154A (en) * 1993-11-08 1995-10-17 American Home Products Corporation N-hydroxyureas as 5-lipoxygenase inhibitors and inhibitors of oxidative modification of low density lipoprotein
US5480896A (en) * 1994-01-27 1996-01-02 American Home Products Corporation Aralkyl-1,2,4-oxadiazolidine-3,5-diones as antihyperglycemic agents

Also Published As

Publication number Publication date
DE69106714D1 (en) 1995-02-23
EP0544696A1 (en) 1993-06-09
US5463070A (en) 1995-10-31
EP0544696B1 (en) 1995-01-11
HU9300486D0 (en) 1993-05-28
IE64927B1 (en) 1995-09-20
GR3014913T3 (en) 1995-05-31
IE912971A1 (en) 1992-02-26
TW200470B (fi) 1993-02-21
AU8235391A (en) 1992-03-17
US5334604A (en) 1994-08-02
JPH0678326B2 (ja) 1994-10-05
PT98732A (pt) 1992-07-31
MX9100804A (es) 1992-04-01
ES2067945T3 (es) 1995-04-01
JPH05508654A (ja) 1993-12-02
NO930615D0 (no) 1993-02-22
CA2087437A1 (en) 1992-02-24
FI930772A0 (fi) 1993-02-22
WO1992003425A1 (en) 1992-03-05
FI930772A (fi) 1993-02-22
ATE116971T1 (de) 1995-01-15
DK0544696T3 (da) 1995-06-06
HUT70153A (en) 1995-09-28
DE69106714T2 (de) 1995-05-11
AU645112B2 (en) 1994-01-06
KR930701420A (ko) 1993-06-11
ZA916644B (en) 1993-04-28
NZ239514A (en) 1993-10-26
NO930615L (no) 1993-02-22
IL113141A0 (en) 1995-06-29
US5763467A (en) 1998-06-09
US5646168A (en) 1997-07-08

Similar Documents

Publication Publication Date Title
ZA916644B (en) Hypoglycemic hydroxyurea derivatives
MX9700486A (es) Ligando para receptor de cinasa transmembranal de hepatoma.
AU3707093A (en) Dynamically biased amplifier
GB9319695D0 (en) Substituted-2-phenyl-3-methoxypropenoates as fungicides
AU3305989A (en) 1,3-disubstituted pyrrolidines
EP0621686A3 (en) Amplifier.
HUT67152A (en) Fungicidal, optically active 2-imidazolyne-5-on and 2-imidazolyne-5-tion-derivatives
ITTO940961A0 (it) Cerniera per mobili.
EP0611108A3 (en) Cellphone.
DE59400030D1 (de) Rütteltisch.
AU3869793A (en) 7 beta-substituted-4-aza-5 alpha-cholestan-3-ones as 5 alpha-reductase inhibitors
EP0644551A3 (en) Detection amplification.
AU8553891A (en) 1-(2-arylethyl)-pyrrolidines
MY105128A (en) Bu-3608 derivatives.
TR199501065A2 (tr) Hipokolesterolemik antiateroskleroz ajanlar olarak faydali spirostanil glikosidal kristaller.
EP0656542A3 (en) Impedance simulation.
EP0828493A4 (en) 4.4-DISUBSTITUTED CYCLOHEXANE-1-OL MONOMERS AND RELATED COMPOUNDS
HU9600727D0 (en) Triaryl-ethylene derivatives for use in therapy
EP0636611A3 (en) Optically active 1,4-dihydropyridine derivatives and process for preparing the same.
EP0616432A3 (en) Sense amplifier.
AU4820990A (en) Substituted 3-azabicyclo(3.1.1)heptanes, their production and use
TW265353B (en) A dye composition
TW277114B (en) Desiccation capsule and article provided with the capsule
AU7655191A (en) Working desk case
EP0621227A3 (en) Articulated loading arm for tree trunks.